Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 4, 2023
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
[ Tue, Apr 04th 2023
] - WOPRAI
Mon, April 3, 2023
[ Mon, Apr 03rd 2023
] - WOPRAI
Raghuram Selvaraju Initiated (TRDA) at Strong Buy and Held Target at $25 on, Apr 3rd, 2023
Raghuram Selvaraju of HC Wainwright & Co., Initiated "Entrada Therapeutics, Inc." (TRDA) at Strong Buy and Held Target at $25 on, Apr 3rd, 2023.
Raghuram, nor any peers, have made any analyst calls on TRDA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30